Ginsenoside Re
Cat. No.:YN350220
产品名称: | Ginsenoside Re |
CAS No.: | 52286-59-6 |
Chemical Name: | (6α)-20-(β-D-glucopyranosyloxy)-3β,12β-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside |
Synonyms: | 人参皂苷 Re; Ginsenoside B2; Panaxoside Re; Sanchinoside Re |
分子量: | 947.15 |
分子式: | C₄₈H₈₂O₁₈ |
SMILES: | O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O[C@H]2C[C@]([C@@](CC[C@]3([H])[C@@](C)(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)CC/C=C(C)/C)(C)[C@]3([H])[C@H](O)C5)(C)[C@@]5([H])[C@]6(C)[C@]2([H])C(C)(C)[C@@H](O)CC6)[C@@H]1O[C@@H]7O[C@@H](C)[C@H](O)[C@@H](O)[C@H]7O |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | Ginsenoside Re (Ginsenoside B2) 是一种Panax notoginseng提取物。Ginsenoside Re 可降低 β-淀粉样蛋白 (Aβ)。Ginsenoside Re 还通过抑制JNK和NF-κB发挥抗炎作用。 |
IC50和靶点: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Liang, Y., and Zhao, S.Progress in understanding of ginsenoside biosynthesisPlant Biol. (Stuttg)10(4),415-421(2008)
Chen, C.F., Chiou, W.F., and Zhang, J.T.Comparison of the pharmacological effects of Panax ginseng and Panax quinquefoliumActa Pharmacol. Sin.29(9),1103-1108(2008)
Peng, D., Wang, H., Qu, C., et al.Ginsenoside Re: Its chemistry, metabolism and pharmacokineticsChin. Med.7,2(2012)
Han, D.H., Kim, S.H., Higashida, K., et al.Ginsenoside Re rapidly reverses insulin resistance in muscles of high-fat diet fed ratsMetabolism61(11),1615-1621(2012)
Gao, Y., Yang, M.F., Su, Y.P., et al.Ginsenoside Re reduces insulin resistance through activation of PPAR-γ pathway and inhibition of TNF-α productionJ. Ethnopharmacol.147(2),509-516(2013)
Helms, S.Cancer prevention and therapeutics: Panax ginsengAltern. Med. Rev.9(3),259-274(2004)